Position Description Chronic Disease Prevention Projects: Fill & Download for Free

Medical Specialty Bags Market Expected To Exhibit Steady Growth During The Forecast PeriodThe latest market report published by Credence Research, Inc. “Medical Specialty Bags Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global medical specialty bags market was valued at US$ 6,560.1 Mn in 2017 expanding at a CAGR of 5.4% from 2018 to 2026.Market InsightsMedical specialty bags are specially designed bags for medical conditions which include blood bags, ostomy bags, urine collection bags, bile collection bags, IV bags and others. Medical specialty bags prevent leakage of body fluids and play an important role in disease management and patients with disability. Growing aging population susceptible to chronic diseases is the major market driving factor.For instance, geriatric population are more prone to gastric and stoma complication requiring ostomy bags, CAPD bags for chronic kidney diseases, among others. Moreover, growing surgical procedures and hospitalization globally would boost the demand for medical specialty bags for different procedures and application. Product innovation and development is the key trend followed in the market.For instance, manufacturers are shifting focus from polyvinyl chloride (PVC) and opting for materials that are environment friendly in nature. Some of the non-PVC materials include latex, silicone, and polyethylene as these are cost-effective and pose minimum hazards. The rise in the uptake of online sales channel as a major distribution method, have increased the accessibility and availability of various medical specialty bags. Growing home healthcare coupled with online sales of medical specialty bags would act as the major growth driver during the forecast period.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59257In terms of product type, ostomy bags held the largest share in the global medical specialty bags market. Global rise in the prevalence of Crohn’s diseases, bowel cancers and other gastrointestinal conditions have resulted in the growing demand for ostomy bags. Growing focus on customer centric products by manufacturers and improving patient awareness are few of the driving factors for the growth this market. IV bags, urine collection bags, and blood bags are expected to show promising market growth during the forecast period owing to the surge in hospitalization, growing surgical procedures and rise in home healthcare facility. Inappropriate reimbursement schemes is one of the major restraining factor for the growth of this market.North America held the dominant position in the global medical specialty bags market owing to growing incidence of chronic diseases in the region. According to American Cancer Society, Inc. estimation, there will be 97,220 cases of colon cancer and 43,030 cases of rectal cancer in the United States. Moreover, there will be estimated 1.7 million new cancer cases diagnosed in the region which boost the demand for medical specialty bags market in region. Asia Pacific is projected to soar high during the forecast period owing to growing healthcare infrastructure, hospitalization and medical care products.The emerging countries in the APAC region, such as China and India, offer a big opportunity for the leading players in this market as these countries contain a significantly large pateint pool of under-served patients. The prominent players actively engaged in the medical specialty bags market include B. Braun Melsungen, Baxter International, Coloplast A/S, ConvaTec, Inc., Hollister Incorporated, Fresenius Kabi, Terumo Corporation, Smith’s Medical among others. Being a consolidated market, product innovation, use of environment friendly materials is the major strategy undertaken by the players operating in the market.Key Market Movements:Rising prevalence of chronic diseases and growing geriatric population worldwideRising patient awareness and home healthcare boosting demand for medical specialty productsGrowing surgical procedures globally to drive the market for medical specialty bagsTOC:Chapter 4. Global Medical Specialty Bags Market, Product Type, 2016-2026 (US$ Mn)4.1. Overview4.2. Bile Collection Bags4.3. Ostomy Bags4.4. Resuscitation Bags4.5. Blood Bags4.6. CAPD Bags4.7. Enema Bags4.8. Enternal Feeding Bags4.9. Intravenous Fluid/Infusion Bags4.10. Urine Collection BagsDownload Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59257Chapter 5. Global Medical Specialty Bags Market, by Geography, 2016 – 2026 (US$ Mn)5.1. North America Medical Specialty Bags Market Analysis, 2016 – 20265.1.1. North America Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.1.2. North America Medical Specialty Bags Market, by Country, 2016 – 2026 (US$ Mn)5.1.2.1. U.S.5.1.2.2. Canada5.2. Europe Medical Specialty Bags Market Analysis, 2016 – 20265.2.1. Europe Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.2.2. Europe Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.2.2.1. U.K.5.2.2.2. Germany5.2.2.3. Rest of Europe5.3. Asia Pacific Medical Specialty Bags Market Analysis, 2016 – 20265.3.1. Asia Pacific Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.3.2. Asia Pacific Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.3.2.1. China5.3.2.2. Japan5.3.2.3. Rest of Asia Pacific5.4. Latin America Medical Specialty Bags Market Analysis, 2016 – 20265.4.1. Latin America Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.4.2. Latin America Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.4.2.1. Brazil5.4.2.2. Mexico5.4.2.3. Rest of Latin America5.5. Middle East & Africa Medical Specialty Bags Market, 2016 – 20265.5.1. Middle East & Africa Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.5.2. Middle East & Africa Medical Specialty Bags Market Analysis, by Region, 2016 – 2026 (US$ Mn)5.5.2.1. GCC5.5.2.2. Rest of Middle East & AfricaChapter 6. Company Profiles6.1. B. Braun Melsungen AG6.1.1. Business Description6.1.2. Financial Information (Subject to Data Availability)6.1.3. Product Portfolio6.1.4. News Coverage6.2. Baxter International6.3. Coloplast A/S6.4. ConvaTec, Inc.6.5. Hollister Incorporated6.6. Fresenius SE & Co. KGaA6.7. Medline Industries, Inc.6.8. Terumo Corporation6.9. Nolato AB6.10. Smiths Medical6.11. Macopharma SA...

Medical Specialty Bags Market Expected To Exhibit Steady Growth During The Forecast PeriodThe latest market report published by Credence Research, Inc. “Medical Specialty Bags Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global medical specialty bags market was valued at US$ 6,560.1 Mn in 2017 expanding at a CAGR of 5.4% from 2018 to 2026.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59257Market InsightsMedical specialty bags are specially designed bags for medical conditions which include blood bags, ostomy bags, urine collection bags, bile collection bags, IV bags and others. Medical specialty bags prevent leakage of body fluids and play an important role in disease management and patients with disability. Growing aging population susceptible to chronic diseases is the major market driving factor.For instance, geriatric population are more prone to gastric and stoma complication requiring ostomy bags, CAPD bags for chronic kidney diseases, among others. Moreover, growing surgical procedures and hospitalization globally would boost the demand for medical specialty bags for different procedures and application. Product innovation and development is the key trend followed in the market.For instance, manufacturers are shifting focus from polyvinyl chloride (PVC) and opting for materials that are environment friendly in nature. Some of the non-PVC materials include latex, silicone, and polyethylene as these are cost-effective and pose minimum hazards. The rise in the uptake of online sales channel as a major distribution method, have increased the accessibility and availability of various medical specialty bags. Growing home healthcare coupled with online sales of medical specialty bags would act as the major growth driver during the forecast period.In terms of product type, ostomy bags held the largest share in the global medical specialty bags market. Global rise in the prevalence of Crohn’s diseases, bowel cancers and other gastrointestinal conditions have resulted in the growing demand for ostomy bags. Growing focus on customer centric products by manufacturers and improving patient awareness are few of the driving factors for the growth this market. IV bags, urine collection bags, and blood bags are expected to show promising market growth during the forecast period owing to the surge in hospitalization, growing surgical procedures and rise in home healthcare facility. Inappropriate reimbursement schemes is one of the major restraining factor for the growth of this market.North America held the dominant position in the global medical specialty bags market owing to growing incidence of chronic diseases in the region. According to American Cancer Society, Inc. estimation, there will be 97,220 cases of colon cancer and 43,030 cases of rectal cancer in the United States. Moreover, there will be estimated 1.7 million new cancer cases diagnosed in the region which boost the demand for medical specialty bags market in region. Asia Pacific is projected to soar high during the forecast period owing to growing healthcare infrastructure, hospitalization and medical care products.The emerging countries in the APAC region, such as China and India, offer a big opportunity for the leading players in this market as these countries contain a significantly large pateint pool of under-served patients. The prominent players actively engaged in the medical specialty bags market include B. Braun Melsungen, Baxter International, Coloplast A/S, ConvaTec, Inc., Hollister Incorporated, Fresenius Kabi, Terumo Corporation, Smith’s Medical among others. Being a consolidated market, product innovation, use of environment friendly materials is the major strategy undertaken by the players operating in the market.Key Market Movements:Rising prevalence of chronic diseases and growing geriatric population worldwideRising patient awareness and home healthcare boosting demand for medical specialty productsGrowing surgical procedures globally to drive the market for medical specialty bagsTOC:Chapter 4. Global Medical Specialty Bags Market, Product Type, 2016-2026 (US$ Mn)4.1. Overview4.2. Bile Collection Bags4.3. Ostomy Bags4.4. Resuscitation Bags4.5. Blood Bags4.6. CAPD Bags4.7. Enema Bags4.8. Enternal Feeding Bags4.9. Intravenous Fluid/Infusion Bags4.10. Urine Collection BagsChapter 5. Global Medical Specialty Bags Market, by Geography, 2016 – 2026 (US$ Mn)5.1. North America Medical Specialty Bags Market Analysis, 2016 – 20265.1.1. North America Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.1.2. North America Medical Specialty Bags Market, by Country, 2016 – 2026 (US$ Mn)5.1.2.1. U.S.5.1.2.2. Canada5.2. Europe Medical Specialty Bags Market Analysis, 2016 – 20265.2.1. Europe Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.2.2. Europe Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.2.2.1. U.K.5.2.2.2. Germany5.2.2.3. Rest of Europe5.3. Asia Pacific Medical Specialty Bags Market Analysis, 2016 – 20265.3.1. Asia Pacific Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.3.2. Asia Pacific Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.3.2.1. China5.3.2.2. Japan5.3.2.3. Rest of Asia Pacific5.4. Latin America Medical Specialty Bags Market Analysis, 2016 – 20265.4.1. Latin America Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.4.2. Latin America Medical Specialty Bags Market, by Country/Region, 2016 – 2026 (US$ Mn)5.4.2.1. Brazil5.4.2.2. Mexico5.4.2.3. Rest of Latin America5.5. Middle East & Africa Medical Specialty Bags Market, 2016 – 20265.5.1. Middle East & Africa Medical Specialty Bags Market, by Product Type, 2016 - 2026 (US$ Mn)5.5.2. Middle East & Africa Medical Specialty Bags Market Analysis, by Region, 2016 – 2026 (US$ Mn)5.5.2.1. GCC5.5.2.2. Rest of Middle East & AfricaChapter 6. Company Profiles6.1. B. Braun Melsungen AG6.1.1. Business Description6.1.2. Financial Information (Subject to Data Availability)6.1.3. Product Portfolio6.1.4. News Coverage6.2. Baxter International6.3. Coloplast A/S6.4. ConvaTec, Inc.6.5. Hollister Incorporated6.6. Fresenius SE & Co. KGaA6.7. Medline Industries, Inc.6.8. Terumo Corporation6.9. Nolato AB6.10. Smiths Medical6.11. Macopharma SA...Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/59257

The ideal answer is a combination of both Primary Prevention and treatments that take advantage of the best treatments available.Primary Prevention is responsible for most of the increase in life expectancy during the last century. We haven’t begun to scratch the surface of what is possible with Primary Prevention.Ronald P. Hattis, MD, MPH, described the following three levels in a presentation on August 30, 2013.—1st known use of terms primary and secondary prevention: 1957 report, Prevention of Chronic Disease—Commission on Chronic Illness, sponsored by Commonwealth Fund, Harvard Univ. Press 1957, volume 1 , pp 1-68—- Primary prevention : “averting the occurrence of disease”—- Secondary prevention: “halting the progression of disease from its early unrecognized stage to a more severe one and preventing complications”—- Health promotion, aimed at maintenance of health rather than prevention of diseases—Distinguished as type of prevention separate from primary, which was considered to be “disease-oriented “Note the definition of Primary Prevention. Vol. 85, No. 1, January 1970 of Public Health Reports has an eloquent description of Primary Prevention written by Leonard M. Schuman, M.D.MAN INSTINCTIVELY mends cracked foundations, repairs broken fences, plugs holes in leaky roofs, binds cracked and drooping tree limbs, and, in turn, palliates pain, dialyzes blood for malfunctioning kidneys, and replaces heart valves or even hearts ravaged by disease. Equally instinctively man flinches from a threatened blow, runs from a burning building, turns from a dangerous precipice, and shies from persons with the defacing lesions of an infectious disease. Each act is one of preservation.Each is directed toward avoidance of an uncomfortable and even disastrous outcome.Each is prevention, yet with distinct and grossly under-stressed differences in goals and efficiency of attainment.In the health field, the excision of a tumorous lung is an attempt to cure or arrest the disease or postpone death, and physical therapy and physical rehabilitative procedures for the stroke victim are attempts to minimize disability. The erection of barriers between radiative sources and man is designed to obviate the occurrence of radiation sickness and leukemia, and administration of a specific vaccine will obviate the occurrence of poliomyelitis. Although each approach shares the common characteristics of man's striving for a measure of immortality, there are obvious, distinct differences in the philosophy of its attainment. In secondary prevention, remedial actions cannot compensate for the mental anguish, physical pain, pre-treatment disability, and the loss of productivity and contribution to the community thereby engendered.With primary prevention-the avoidance of disease itself-and the maintenance of health, however, none of these deleterious and impoverishing situations are encountered.Paradoxically, the readily recognized advantages of primary prevention over arrest or cure of disease have not been fully exploited. Generations have passed since mankind's observations and experiences led to the aphorism that "an ounce of prevention is worth a pound of cure," yet only lip service has been given to this imperative in social behavior. It is deplorable that so much human waste has been tolerated when alternatives have been available.We cannot countenance the continuance of such dereliction in the face of evolving knowledge in primary prevention.[1]Nearly 50 years after Dr. Schumann wrote those words, I decry the same sad state of affairs.Why?Follow the MoneyNo system has been established to pay people to educate society about strategies of Primary Prevention. Our established systems pay to treat illnesses that have been diagnosed. The diagram in this post illustrates this concept clearly when it comes to mental health.Our language around prevention has morphed so that we rarely talk about Primary Prevention. Most people think of secondary prevention when they hear the word prevention. Corporate wellness programs focus on secondary prevention and ignore primary prevention opportunities that would bear greater fruit and higher returns on investment.Most Primary Prevention education is done through uncompensated work by individuals such as myself who are passionate about sharing the information. A tiny bit of Primary Prevention is done in schools. Most of the potential from Primary Prevention remains untapped.In my work, I have separated habits of thought into those known to lead to optimal outcomes and those known to lead to sub-optimal outcomes. At the time I created the following charts I was still using the older terms of “negative habits of thought” which has now been replaced with “unhealthy habits of thought” in my work.By reading research from many different branches of science, a consistent pattern was revealed to me. Unhealthy habits of thought increase the daily and cumulative stress an individual experiences. Chronic stress worsens the outcomes in every area of life. These charts were created to illustrate the relationship between chronic stress and outcomes individuals experience.Source: (c) Jeanine Joy, 2015When we begin with healthy habits of thought, the outcomes in all the above areas improve.Habits of thought are like any other habit. They can be changed. Anyone with information about how to change their habits of thought can do so on their own and minimize their risk of developing illnesses and diseases and especially the risk of developing chronic illnesses that lead to long-term decrements in functioning prior to death.Individuals with healthy habits of thought enjoy an average of eighteen extra healthy years, including about 10.7 extra years of life. Individuals with unhealthy habits of thought tend to experience 6 - 8 years of chronic illnesses before their earlier deaths. These numbers are supported by two longitudinal studies that studied groups for seventy years.[2] , [3]The following charts illustrate the average difference in experience of individuals who have healthy habits of thought and unhealthy habits of thought with a cohort where the individual with unhealthy habits of thought develops a chronic illness at age 50 and at age 70.When I first became aware of the difference in life expectancy based on healthy and unhealthy habits of thought, I frequently heard the response that someone didn’t want to add more years at the end of life when they were sick. When I dug deeper and learned that unhealthy habits of thought are associated with longer periods of disability prior to death even though death occurred about ten years earlier, that response no longer presented a valid argument.In the time since I created the above charts, more information about epigenetic changes that affect our health and the health of our offspring and future generations has been published. Today, we know that chronic stress can flip epigenetic switches and turn on undesired outcomes that are potential outcomes until the switch is flipped. We also know that the stress we experience can negatively affect which switches are flipped in our children’s DNA/RNA.We have known the detrimental effects of stress on our body and mind since the 1970’s. Today we have good solutions. Advanced and Transformational Stress Management strategies and greater understanding of the purpose of emotions has given us a giant leap forward. This information should be given to every student and every adult. The potential to greatly diminish the incidents of chronic illnesses and other adverse outcomes is fabulous but the knowledge is useless if no one knows about it.I didn’t start out to learn what I know about this. I began with a question that I wanted an answer to that grew into a hobby that became a passion and once I had the answers and recognized their potential, changed my life because I left a lucrative and rewarding career to spread the word about what I’d learned. No one who is in a single silo of science will see all these relationships. It takes someone who is reading research in many silo’s to see the pattern.When I worked in risk management and compliance, we were sometimes asked to document how much money we saved the company by preventing lawsuits and malfeasance. Since lawsuits that are not filed cannot be known, it is impossible to calculate accurately. In a changing legal landscape, it is not possible to compare prior suits to suits after new strategies are implemented when laws are continually changing. The best we could do was compare our results to those at companies without robust compliance and risk management programs.In the same way, it is difficult to calculate how much is saved by preventing illnesses is difficult to calculate. What is the value of keeping someone alive and healthy vs. a pre-mature death? We can’t know who would have become ill and died without Primary Prevention. If the prevented death is your child, the value of prevention is priceless.What is Primary Prevention and Why Does It Matter?Life expectancy has doubled over the past 150 years. How is that possible? A recent study showed that most Americans would credit 80% of the improvement to advances in medical science. Historians would disagree.The greatest increase in life expectancy occurred between 1880 and 1920, before the advent of antibiotics, chemotherapy, drugs to reduce blood pressure and advanced surgical techniques. In fact, most of the credit mathematically goes to improved supplies of clean (or chlorinated) drinking water in urban areas. In 1854, a cholera epidemic in London was linked to a water pump next to a leaky sewer. By the early 1900s, big public works projects had the immediate result that more children survived infancy and childhood. In addition, better nutrition, better (less crowded) housing, better understanding of germ science and food contamination and better standards of living were also big contributors.In 1999, the Centers for Disease Control (CDC) estimated that of the 30 years in life expectancy gained since 1900, only five of those years might be attributed to medical advances.[4]Primary Prevention includes:Clean drinking waterSanitationWaste removal (garbage collection)SewersHealthy lifestyle choicesHand-washingSeatbeltsCondomsWhen James Finn writes about safe sex, he is encouraging a form of Primary Prevention.ExerciseGood nutritionAccess to foodFood ChoicesWhen Liang-Hai Die writes about diet and nutrition, it is a form of educational primary prevention.We make better food choices when we have healthy habits of thought than when we have unhealthy habits of thought.[5]Safety netsImmunizationsHealthy habits of thought are natural. Most unhealthy habits of thought were taught to us by parents, clergy, and teachers who had good intentions but didn’t have the advantage of the research that has been published over the past two decades.Some researchers still say our habits of thought are genetic. Those of us who teach individuals, including individuals who have no memory of having anything other than unhealthy habits of thought across their lifespan until they learn strategies that help them develop healthy habits of thought, disagree. We disagree adamantly. I invite any researcher who would like to study this to partner with me and watch the changes that are possible when the right strategies are provided. Dr. Robert Holden and I first discussed the literature that points to genetics in 2011 and we were in complete agreement that they simply hadn’t designed the right type of study.When you’ve seen the transformations that could be called metamorphosis, you know what is possible.Knowing the potential for human health, knowing what we could achieve with greater emphasis on health promotion at the root cause, it is better to preserve the natural health of the body than to wait until an illness manifests to think about wellness. Once an illness manifests, the best strategy is often a combination of improving the environment which includes reducing stress and using modern medicine.I have known quite a few people who used both after being diagnosed with Type II Diabetes who were able to stop the medical intervention (under physician supervision) after using it to stabilize their condition while they worked on other factors that were contributing to the illness. I’m not sure that they would have lived long enough to make those changes without modern medicine.Asking a question that elicits a negative emotional response from most people isn’t the most productive path. Asking how we can use the best of both our body’s natural healing resources and modern medicine to extend wellness and improve illnesses when they do occur might lead to collaboration and progress.Footnotes:Boehm, J. K. (2012, July). The heart's content: The association between positive psychological well-being and cardiovascular health. Psychological Bulletin, Epub April 2012, 138(4):655-91.Danner, D. D. (2001). "Positive Emotions in Early Life and Longevity: Findings from the Nun Study." . Journal of Personality and Social Psychology., 804-13.Upper Peninsula Community Health Needs Assessments. (2016). Phase II: Lessons Learned & Summary of Findings. CHNA.Vaillant, G. E. (2012). Triumphs of Experience: The Men of the Harvard Grant Study.Footnotes[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2031637/[2] http://Danner, D. D. (2001)[3] http://Vaillant, G. E. (2012)[4] http://UPPER PENINSULA COMMUNITY HEALTH NEEDS ASSESSMENTS Phase II: Lessons Learned & Summary of Findings | April 2016[5] http://Boehm, 2012